Prosultiamine/ja: Difference between revisions
Prosultiamine/ja
Created page with "プロスルチアミン" Tags: Mobile edit Mobile web edit |
Created page with "<!--Chemical data--> | C=15 | H=24 | N=4 | O=2 | S=2 | smiles = O=CN(\C(=C(\SSCCC)CCO)C)Cc1cnc(nc1N)C }}" |
||
| Line 1: | Line 1: | ||
<languages /> | <languages /> | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name = ''N''-[(4-amino-2-methylpyrimidin-5-yl)methyl]-''N''-[(1''E'')-4-hydroxy-1-methyl-2-(propyldisulfanyl)but-1-en-1-yl]formamide | | IUPAC_name = ''N''-[(4-amino-2-methylpyrimidin-5-yl)methyl]-''N''-[(1''E'')-4-hydroxy-1-methyl-2-(propyldisulfanyl)but-1-en-1-yl]formamide | ||
| image = Prosultiamine.png | | image = Prosultiamine.png | ||
| alt = | | alt = プロスルチアミンの骨格式 | ||
| width = 240 | | width = 240 | ||
| image2 = Prosultiamine 3D ball.png | | image2 = Prosultiamine 3D ball.png | ||
| alt2 = | | alt2 = プロスルチアミン分子のボール＆スティックモデル | ||
| width2 = 260 | | width2 = 260 | ||
<!--Clinical data--> | <!--Clinical data--> | ||
| tradename = | | tradename = | ||
| Line 19: | Line 15: | ||
| legal_status = Rx-only | | legal_status = Rx-only | ||
| routes_of_administration = [[Mouth|Oral]] | | routes_of_administration = [[Mouth|Oral]] | ||
<!--Pharmacokinetic data--> | <!--Pharmacokinetic data--> | ||
| bioavailability = | | bioavailability = | ||
| Line 27: | Line 21: | ||
| elimination_half-life = | | elimination_half-life = | ||
| excretion = | | excretion = | ||
<!--Identifiers--> | <!--Identifiers--> | ||
| CAS_number = 59-58-5 | | CAS_number = 59-58-5 | ||
| Line 38: | Line 30: | ||
| UNII_Ref = {{fdacite|correct|FDA}} | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| UNII = UI32MM3XE3 | | UNII = UI32MM3XE3 | ||
<!--Chemical data--> | <!--Chemical data--> | ||
| C=15 | H=24 | N=4 | O=2 | S=2 | | C=15 | H=24 | N=4 | O=2 | S=2 | ||
| smiles = O=CN(\C(=C(\SSCCC)CCO)C)Cc1cnc(nc1N)C | | smiles = O=CN(\C(=C(\SSCCC)CCO)C)Cc1cnc(nc1N)C | ||
}} | }} | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> | ||